Drug maker Affymax Inc (NASDAQ: AFFY) is having a pocket pivot in today's trade if it can close in the top half of its trading range.
AFFY develops peptide-based drugs that combat anemia associated with chronic renal failure. AFFY recently secured a supply agreement with a German provider of dialysis treatments through 2,898 clinics in over 40 countries, Fresenius Medical Ads (NYSE: FMS). It is a positive step in AFFY’s attempts to penetrate the dialysis segment, and some analysts believe this could make AFFY a takeover target.
AFFY recently had a very strong trendline breakout on huge volume and, after running up sharply, the stock has formed a short, tight flag as volume declines, indicating that investors are not willing to dump the stock here despite a rocky general market environment.
AFFY has had no earnings up until its most recent quarter. Thus it carries more risk that the larger, more established companies such as Biogen (BIIB). That said, with greater risk comes more potential reward when the company’s fundamentals and product pipeline show strong promise.
This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2021 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.